Percutaneous radiofrequency ablation of lung tumors: Evaluation of the literature using evidence-based techniques

Journal of Thoracic Imaging

Volumn 26, Issue 1, 2011, Pages 18-26

  Chan, Victoria O ^a   McDermott, Shaunagh ^a   Malone, Dermot E ^a   Dodd, Jonathan D ^a  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

adult; catheter ablation; computed tomography; human; neoplasms diagnosis; treatment outcome

Indexed keywords

ARTICLE; BRONCHOPLEURAL FISTULA; CANCER RECURRENCE; CANCER SIZE; CANCER SURGERY; CANCER SURVIVAL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONSCIOUS SEDATION; EPIDURAL ANESTHESIA; FEVER; FOLLOW UP; GENERAL ANESTHESIA; HEMOPTYSIS; HUMAN; LUNG ABSCESS; LUNG ADENOCARCINOMA; LUNG ALVEOLUS CELL CARCINOMA; LUNG CANCER; LUNG METASTASIS; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; OVERALL SURVIVAL; PLEURA EFFUSION; PNEUMONIA; PNEUMOTHORAX; POSTOPERATIVE PAIN; RADIOFREQUENCY ABLATION; SUBCUTANEOUS EMPHYSEMA; SYSTEMATIC REVIEW; THORAX DRAINAGE;

CATHETER ABLATION; DATABASES AS TOPIC; EVIDENCE-BASED MEDICINE; HUMANS; LUNG NEOPLASMS;

EID: 79551552325     PISSN: 08835993     EISSN: None     Source Type: Journal    
DOI: 10.1097/RTI.0b013e3181e48d5e     Document Type: Article

References (80)

1. Jemal A, Thun MJ, Ries LAG, et al. Annual report to the nation on the status of cancer, 1975-2005, featuring trends in lung cancer, tobacco use, and tobacco control. J Natl Cancer Inst. 2008;100:1672-1694.
2. Little AG, Gay EG, Gaspar LE, et al. National survey of nonsmall cell lung cancer in the United States: epidemiology, pathology and patterns of care. Lung Cancer. 2007;57:253-260.
3. Janssen-Heijnen ML, Schipper RM, Razenberg PP, et al. Prevalence of co-morbidity in lung cancer patients and its relationship with treatment: a population-based study. Lung Cancer. 1998;21:105-113.
4. McGarry RC, Song G, des Rosiers P, et al. Observation-only management of early stage, medically inoperable lung cancer: poor outcome. Chest. 2002;121:1155-1158.
5. Powell JW, Dexter E, Scalzetti EM, et al. Treatment advances for medically inoperable non-small-cell lung cancer: emphasis on prospective trials. Lancet Oncol. 2009;10:885-894.
6. Lencioni R, Crocetti L, Cioni R, et al. Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study). Lancet Oncol. 2008;9:621-628.
7. Gillams A. Lung tumour ablation-where are we now? Cancer Imaging. 2008;8:116-117.
8. Hiraki T, Gobara H, Mimura H, et al. Percutaneous radiofrequency ablation of lung cancer. Lancet Oncol. 2008;9:604-605.
9. Dupuy DE, Zagoria RJ, Akerley W, et al. Percutaneous radiofrequency ablation of malignancies in the lung. AJR Am J Roentgenol. 2000;174:57-59.
10. Simon CJ, Dupuy DE, DiPetrillo TA, et al. Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients. Radiology. 2007;243:268-275.
11. Malone DE. Evidence-based practice in radiology: an introduction to the series1. Radiology. 2007;242:12-14.
12. Staunton M. Evidence-based radiology: steps 1 and 2-asking answerable questions and searching for evidence. Radiology. 2007;242:23-31.
13. Google. Available at: http://www.google.com.
14. National Library of Medicine and National Institutes of Health. Available at: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=mesh.
15. Haynes R. The evidence pyramid. ACP Journal Club. 2001;134: A11-A13.
16. Fernando HC, De Hoyos A, Landreneau RJ, et al. Radiofrequency ablation for the treatment of non-small cell lung cancer in marginal surgical candidates. J Thorac Cardiovasc Surg. 2005;129:639-644.
17. Clinical Evidence homepage. Available at: http://www.clinicalevidence. com/ceweb/conditions/index.jsp.
18. American College of Physicians Journal Club homepage. Available at: http://www.acpjc.org/.
19. Cochrane Collaboration homepage. Available at: http://cochrane.org.
20. The Centre for Evidence-Based Medicine, Oxford University (England). Available at: URL: http://cebm.net/levels of evidence.asp#levels.
21. Maher MM, Hodnett PA, Kalra MK. Evidence-based practice in radiology: steps 3 and 4-appraise and apply interventional radiology literature. Radiology. 2007;242:658-670.
22. Schirmang TC, Dupuy DE. Radiofrequency ablation of lung cancers. Journal [serial on the Internet]. Date: Available from: http://www.uptodate.com.
23. Badgett B, Levy L. SUMSearch. Available at: http://sumsearch.uthscsa.edu/ .
24. Nishida T, Inoue K, Kawata Y, et al. Percutaneous radiofrequency ablation of lung neoplasms: a minimally invasive strategy for inoperable patients. J Am Coll Surg. 2002;195:426-430.
25. Suh RD, Wallace AB, Sheehan RE, et al. Unresectable pulmonary malignancies: CT-guided percutaneous radiofrequency ablation-preliminary results. Radiology. 2003;229:821-829.
26. Herrera LJ, Fernando HC, Perry Y, et al. Radiofrequency ablation of pulmonary malignant tumors in nonsurgical candidates. J Thorac Cardiovasc Surg. 2003;125:929-937.
27. Steinke K, King J, Glenn D, et al. Radiologic appearance and complications of percutaneous computed tomography-guided radiofrequency-ablated pulmonary metastases from colorectal carcinoma. J Comput Assist Tomogr. 2003;27:750-757.
28. Jin GY, Lee JM, Lee YC, et al. Primary and secondary lung malignancies treated with percutaneous radiofrequency ablation: evaluation with follow-up helical CT. AJR Am J Roentgenol. 2004;183:1013-1020.
29. Belfiore G, Moggio G, Tedeschi E, et al. CT-guided radiofrequency ablation: a potential complementary therapy for patients with unresectable primary lung cancer-a preliminary report of 33 patients. AJR Am J Roentgenol. 2004;183:1003-1011.
30. Yasui K, Kanazawa S, Sano Y, et al. Thoracic tumors treated with CT-guided radiofrequency ablation: initial experience. Radiology. 2004;231:850-857.
31. Gadaleta C, Mattioli V, Colucci G, et al. Radiofrequency ablation of 40 lung neoplasms: preliminary results. AJR Am J Roentgenol. 2004;183:361-368.
32. Steinke K, Glenn D, King J, et al. Percutaneous imagingguided radiofrequency ablation in patients with colorectal pulmonary metastases: 1-year follow-up. Ann Surg Oncol. 2004;11:207-212.
33. King J, Glenn D, Clark W, et al. Percutaneous radiofrequency ablation of pulmonary metastases in patients with colorectal cancer. Br J Surg. 2004;91:217-223.
34. Akeboshi M, Yamakado K, Nakatsuka A, et al. Percutaneous radiofrequency ablation of lung neoplasms: initial therapeutic response. J Vasc Interv Radiol. 2004;15:463-470.
35. Lee JM, Jin GY, Goldberg SN, et al. Percutaneous radiofrequency ablation for inoperable non-small cell lung cancer and metastases: preliminary report. Radiology. 2004;230:125-134.
36. Bojarski JD, Dupuy DE, Mayo-Smith WW. CT imaging findings of pulmonary neoplasms after treatment with radiofrequency ablation: results in 32 tumors. AJR Am J Roentgenol. 2005;185:466-471.
37. Van Sonnenberg E, Shankar S, Morrison PR, et al. Radiofrequency ablation of thoracic lesions: part 2, initial clinical experience-technical and multidisciplinary considerations in 30 patients. AJR Am J Roentgenol. 2005;184:381-390.
38. Hoffmann RT, Jakobs TF, Lubienski A, et al. Percutaneous radiofrequency ablation of pulmonary tumors-is there a difference between treatment under general anaesthesia and under conscious sedation?. Eur J Radiol. 2006;59:168-174.
39. Gadaleta C, Catino A, Mattioli V. Radiofrequency thermal ablation in the treatment of lung malignancies. In Vivo. 2006;20:765-767.
40. Hiraki T, Sakurai J, Tsuda T, et al. Risk factors for local progression after percutaneous radiofrequency ablation of lung tumors: evaluation based on a preliminary review of 342 tumors. Cancer. 2006;107:2873-2880.
41. Kishi K, Nakamura H, Kobayashi K, et al. Percutaneous CT-guided radiofrequency ablation of pulmonary malignant tumors: preliminary report. Intern Med. 2006;45:65-72.
42. De Baere T, Palussiere J, Auperin A, et al. Midterm local efficacy and survival after radiofrequency ablation of lung tumors with minimum follow-up of 1 year: prospective evaluation. Radiology. 2006;240:587-596.
43. Rossi S, Dore R, Cascina A, et al. Percutaneous computed tomography-guided radiofrequency thermal ablation of small unresectable lung tumours. Eur Respir J. 2006;27:556-563.
44. Yan TD, King J, Sjarif A, et al. Percutaneous radiofrequency ablation of pulmonary metastases from colorectal carcinoma: prognostic determinants for survival. Ann Surg Oncol. 2006;13:1529-1537.
45. Okuma T, Okamura T, Matsuoka T, et al. Fluorine-18-fluorodeoxyglucose positron emission tomography for assessment of patients with unresectable recurrent or metastatic lung cancers after CT-guided radiofrequency ablation: preliminary results. Ann Nucl Med. 2006;20:115-121.
46. Thanos L, Mylona S, Pomoni M, et al. Percutaneous radiofrequency thermal ablation of primary and metastatic lung tumors. Eur J Cardiothorac Surg. 2006;30:797-800.
47. Volpe ML, Piazza O, Palumbo D, et al. Conscious analgosedation for radiofrequency ablation of lung neoplasm. Minerva Anesthesiol. 2006;72:111-115.
48. Yan TD, King J, Sjarif A, et al. Learning curve for percutaneous radiofrequency ablation of pulmonary metastases from colorectal carcinoma: a prospective study of 70 consecutive cases. Ann Surg Oncol. 2006;13:1588-1595.
49. Lagana D, Carrafiello G, Mangini M, et al. Radiofrequency ablation of primary and metastatic lung tumors: preliminary experience with a single center device. Surg Endosc. 2006;20:1262-1267.
50. Grieco CA, Simon CJ, Mayo-Smith WW, et al. Percutaneous image-guided thermal ablation and radiation therapy: outcomes of combined treatment for 41 patients with inoperable stage I/II non-small-cell lung cancer. J Vasc Interv Radiol. 2006;17:1117-1124.
51. Dupuy DE, DiPetrillo T, Gandhi S, et al. Radiofrequency ablation followed by conventional radiotherapy for medically inoperable stage I non-small cell lung cancer. Chest. 2006;129:738-745.
52. Hiraki T, Tajiri N, Mimura H, et al. Pneumothorax, pleural effusion, and chest tube placement after radiofrequency ablation of lung tumors: incidence and risk factors. Radiology. 2006;241:275-283.
53. Pennathur A, Luketich JD, Abbas G, et al. Radiofrequency ablation for the treatment of stage I non-small cell lung cancer in high-risk patients. J Thorac Cardiovasc Surg. 2007;134:857-864.
54. Ambrogi MC, Dini P, Melfi F, et al. Radiofrequency ablation of inoperable non-small cell lung cancer. J Thorac Oncol. 2007;2: S2-S3.
55. Iguchi T, Hiraki T, Gobara H, et al. Percutaneous radiofrequency ablation of lung tumors close to the heart or aorta: evaluation of safety and effectiveness. J Vasc Interv Radiol. 2007;18:733-740.
56. Cariati M, Giordano G, Midulla M, et al. Radiofrequency ablation of pulmonary lesions. Radiol Med. 2007;112:149-156.
57. Hiraki T, Gobara H, Iishi T, et al. Percutaneous radiofrequency ablation for pulmonary metastases from colorectal cancer: midterm results in 27 patients. J Vasc Interv Radiol. 2007;18:1264-1269.
58. Yamakado K, Hase S, Matsuoka T, et al. Radiofrequency ablation for the treatment of unresectable lung metastases in patients with colorectal cancer: a multicenter study in Japan. J Vasc Interv Radiol. 2007;18:393-398.
59. Hiraki T, Gobara H, Iishi T, et al. Percutaneous radiofrequency ablation for clinical stage I non-small cell lung cancer: results in 20 nonsurgical candidates. J Thorac Cardiovasc Surg. 2007;134:1306-1312.
60. Sano Y, Kanazawa S, Gobara H, et al. Feasibility of percutaneous radiofrequency ablation for intrathoracic malignancies: a large single-center experience. Cancer. 2007;109:1397-1405.
61. Yan TD, King J, Ebrahimi A, et al. Hepatectomy and lung radiofrequency ablation for hepatic and subsequent pulmonary metastases from colorectal carcinoma. J Surg Oncol. 2007;96:367-373.
62. Gillams AR, Lees WR. Analysis of the factors associated with radiofrequency ablation-induced pneumothorax. Clin Radiol. 2007;62:639-644.
63. Choe YH, Kim SR, Lee KS, et al. The use of PTC and RFA as treatment alternatives with low procedural morbidity in nonsmall cell lung cancer. Eur J Cancer. 2009;45:1773-1779.
64. Pennathur A, Abbas G, Qureshi I, et al. Radiofrequency ablation for the treatment of pulmonary metastases. Ann Thorac Surg. 2009;87:1030-1036; discussion 6-9.
65. Lanuti M, Sharma A, Digumarthy SR, et al. Radiofrequency ablation for treatment of medically inoperable stage I nonsmall cell lung cancer. J Thorac Cardiovasc Surg. 2009;137:160-166.
66. Zhu JC, Yan TD, Glenn D, et al. Radiofrequency ablation of lung tumors: feasibility and safety. Ann Thorac Surg. 2009;87:1023-1028.
67. Steinke K, King J, Glenn D, et al. Radiofrequency ablation (RFA) of lung metastases from colorectal cancer (CRC)-oneyear follow-up. Radiologe. 2004;44:687-692.
68. Hiraki T, Gobara H, Takemoto M, et al. Percutaneous radiofrequency ablation combined with previous bronchial arterial chemoembolization and followed by radiation therapy for pulmonary metastasis from hepatocellular carcinoma. J Vasc Interv Radiol. 2006;17:1189-1193.
69. Zhu JC, Yan TD, Morris DL. A systematic review of radio frequency ablation for lung tumors. Ann Surg Oncol. 2008;15:1765-1774.
70. Talton BM, Constable WC, Kersh CR. Curative radiotherapy in non-small cell carcinoma of the lung. Int J Radiat Oncol Biol Phys. 1990;19:15-21.
71. Pastorino U, Buyse M, Friedel G, et al. Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases. J Thorac Cardiovasc Surg. 1997;113:37-49.
72. Sackett DL, Straus SE, Richardson WS, et al. Evidence-based Medicine, how to Practice and Teach EBM. 2nd ed. Edinburgh: Churchill Livingstone; 2000.
73. Radiofrequency Ablation in Treating Patients With Stage I Non-Small Cell Lung Cancer. Available at: http://clinical-trials.gov/ct2/show/NCT00109876.
74. Onishi H, Shirato H, Nagata Y, et al. Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study. J Thorac Oncol. 2007;2: S94-S100.
75. Fakiris AJ, McGarry RC, Yiannoutsos CT, et al. Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: four-year results of a prospective phase II study. Int J Radiat Oncol Biol Phys. 2009;75:677-682.
76. Qiao X, Tullgren O, Lax I, et al. The role of radiotherapy in treatment of stage I non-small cell lung cancer. Lung Cancer. 2003;41:1-11.
77. Le QT, Loo BW, Ho A, et al. Results of a phase I doseescalation study using single-fraction stereotactic radiotherapy for lung tumors. J Thorac Oncol. 2006;1:802-809.
78. Timmerman R, McGarry R, Yiannoutsos C, et al. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol. 2006;24:4833-4839.
79. Denys A, deBaere T, Kuoch V, et al. Radio-frequency tissue ablation of the liver: in vivo and ex vivo experiments with four different systems. Eur Radiol. 2003;13:2346-2352.
80. Hiraki T, Mimura H, Gobara H, et al. Two cases of needletract seeding after percutaneous radiofrequency ablation for lung cancer. J Vasc Interv Radiol. 2009;20:415-418.